
Curicef TZ 250mg/31.25mg Injection
Marketer
Curelab Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Curicef TZ 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg), sold as Curicef TZ, combats diverse bacterial infections. This combined medication inhibits microbial growth, halting infection spread. Administration must be under a doctor's direct supervision; complete the prescribed course, even with symptom improvement, as premature cessation reduces effectiveness. Potential side effects include nausea, vomiting, diarrhea, and indigestion. Severe side effects or allergic reactions (rash, itching, swelling, breathing difficulty) necessitate immediate medical attention. Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While driving impairment is uncommon, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and hydration are crucial for optimal recovery. Your doctor might order tests to monitor the medication's efficacy.
Primary Ingredients of Curicef TZ 250mg/31.25mg Injection
No text provided to rephrase.
Uses of Curicef TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Curicef TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Curicef TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Curicef TZ 250mg/31.25mg Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
How Curicef TZ 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam (Curicef TZ 250mg/31.25mg Injection) combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their survival. The addition of Tazobactam overcomes bacterial resistance, thereby optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Curicef TZ 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Curicef TZ 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Curicef TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Curicef TZ 250mg/31.25mg Injection could lead to drowsiness, blurred vision, and dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Curicef TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Curicef TZ (250mg/31.25mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Altering the dose of Curicef TZ (250mg/31.25mg) injection is not advised for those with mild or moderately compromised liver function.
What if you forget to take Curicef TZ 250mg/31.25mg Injection :
Should you forget a scheduled injection of Curicef TZ 250mg/31.25mg, seek your physician's advice.
Facts to Know About Curicef TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
